ArticleCancer biology & therapy2014

MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells.

Lucy Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.